Losartan Potassium Tablets, 25 Mg Tablet
Product Images NDC 63629-2426

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 25 Mg (NDC 63629-2426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
The text provides information on a study involving patients with fatal and non-fatal stroke. The study compares the use of Atenolol and Losartan Potassium in reducing the risk of stroke. The adjusted risk reduction was found to be 25%, with a significance level of p=0.001. The study spanned over 66 months.*
FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
FDA Label Image

Figure 4.jpg (Figure4)

Figure 4.jpg (Figure4)
FDA Label Image

Label (Lbl636292426)

Label (Lbl636292426)
This text is describing a medication called NILD that contains Losartan Potassium, USP 25mg. The medication should be kept out of reach of children and stored in a tight, light-resistant container at 20° to 25°C. The medication comes in a pack of 1000 tablets with a prescription required for purchase. The rest of the text is not readable.*
FDA Label Image

Losartan Potassium, Usp (Structure)

Losartan Potassium, Usp (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.